Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: cancer + lung + 628,000  Related to the article below (Last Update: 8/5/2008)

FDA Reviewing Biomoda Submission for Cancer Screening Study
MarketWatch -
Biomoda's patented technology is designed for early lung cancer screening of large populations at a reasonable cost. The non-invasive test, ...OTC:BMOD
Nastech Pharmaceutical Company Inc. Q2 2008 Earnings Call Transcript
Seeking Alpha, NY -
In oncology, we are pursuing indications in bladder cancer and lung cancer. Bladder cancer is the fifth most common cancer in the United States and seventh ...MRNA
Epigenomics AG Reports First Half of 2008 Results
FOXBusiness - 30 minutes ago
In Q2 2008, Epigenomics successfully completed two clinical studies in its lung cancer program. Both studies were run in close collaboration with the ...FRA:ECX - DGX - EBR:ONCOB

TheMedGuru
Prostate Tests for Men Older Than 74 Not Always Worthwhile
Bloomberg -
Prostate cancer is the second-most common malignancy among men in the US, after skin cancer, and the second-leading killer for men, after lung tumors, ...
Not All Men Need Prostate Cancer Screening ABC News
Prostate Cancer Screening Not For Men Over 75: Panel TheMedGuru
Task Force Says Men Age 75 and Older Should Not Be Screened For ... Earthtimes (press release)
all 261 news articles »
Radiofrequency Ablation Effective for Primary Lung Tumors and Lung ...
Cancer Consultants, ID -
The use of radiofrequency ablation for the treatment of lung cancer and lung metastases from breast, colon, and prostate cancers and melanoma is effective ...
Postsurgical Antibiotic Therapy Decreases Metachronous Recurrences ... Cancer Consultants
In Gastric Cancer Antibiotics Following Surgery Reduce Risk of ... Cancer Consultants
all 3 news articles »

Ottawa Citizen
Breast cancer diagnosis ... and the outcome
Los Angeles Times, CA -
Although breast cancer remains the second-leading cause of cancer death in women (far behind lung cancer), Applegate's disease was caught in the early ...
AssociatedPress
all 975 news articles »
Washington Univ. prof wins $728K grant for cancer research
Bizjournals.com, NC -
McQueen said about 40 percent of early-stage lung cancer patients continue or return to smoking within a year. She is interested in working with these ...
American Lung Association Offers Olympic Spectators Tips to Stay ...
MarketWatch -
It can also increase the risk of heart attacks, strokes, lung cancer and even early death. Before spectators leave for Beijing, the American Lung ...
Gene Test Leads To Targeted Cancer Treatment
cbs4denver.com, CO -
Lung cancer is one of the deadliest forms of cancer. When it's caught early it can be treated, but most patients are diagnosed in the later stages of the ...
Health Screenings Help Uninsured In Denver cbs4denver.com
all 2 news articles »
YM BIOSCIENCES REPORTS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC ...
FOXBusiness -
We intend to file for registration trials in 2008 for patients with non small cell lung cancer (NSCLC) and for those with brain metastases because of ...YMI - OTC:CMTX
Source: Google News

[PDF] ???????????????????? -
???, ???, ??, ???, ??, ???, … - ????????, 2001 - shouxi.net
... with or without concurrent chemotherapy[J ]. Lung Cancer , 1995 , 13(1 ... ????? ;
?? 610083 ; 4 ???????????? , ?? 628000) ...

[PDF] ????
???, ??? - ????????, 2001 - shouxi.net
... 2 small 2 cell lung cancer ???,??? ( ????????
????? , ?? 361004) ??????????? ...

? ? ?? ? ?, ?? ?? ? ?? ?? ? ? ??
??, ?? ?, ?? ? - ?? ?? ??, 2006 - ????
... Guangyuan TCM Hospital ot Siehuan Province?Guangyuan 628000,Sichuan Province ...
radieulopathy,tubercle,tumor(osseous metastasis of lung cancer)and fracture ...
-

Smoking cessation: a role for every practitioner -
J Roberts - British Journal of Community Nursing, 2002 - internurse.com
... dis- ease, causing between 85% and 90% of deaths from lung cancer and chronic ... In
1997, cigarette smoking accounted for an estimated 117400 of 628000 deaths in ...
-

?? ? ?? ?? ?? ? ?? 138 ?
?? ?, ?? - ?? ?? ? ??, 2002 - ????
... the radical surgery of cancer of esophagus ... of their symptoms and lung functions
were ... ???(???????,????628000) ????:1005 ...
-

?? ?? CA15?3, TNF?a, GPDA, ADA ? ?? ? ? ?? ?? ?? ? ?? -
?? ?, ???, ?? ?, ?? ? - ?? ?? ?? ??, 2005 - ????
... t (1.?????????????,????628000;2.????????
????? ... vanced non small cell lung cancer patients EJ ...

?? ? ?? ?? ? ? ?? ?? ? ?? ??
?? ?, ?? ? - ? ? ?? ?? ??, 2001 - ????
... n?ln-~nall-cdl lung?treated th ... erapy[J] hmE Cancer,1995.13 ... ??610083;
????????????,??628000) ??????(Severe ...
-

?? ? ? ? ?? ? ? ? ?? ?? ? ?? -
?? ?, ?? ?, ?? ?, ?? ? - ?? ?? ? ??, 2004 - ????
... Guang Yuan City,Sichuan Guangyuan 628000,China) Abstract ... erspiration function after
esophageal cancer?S beingcut ... Results The data of lung funetion before ...
-

? ? ? ?? ? ? ?? ? ? ?? ?? ? ?? ??
?? ?, ?? - ? ? ?? ?? ??, 2001 - ????
... n?ln-~nall-cdl lung?treated th ... erapy[J] hmE Cancer,1995.13 ... ??610083;
????????????,??628000) ??????(Severe ...

?? ? ? ? ?? ?? ?? ?? -
?? ?, ?? ?, ?? ?, ?? ? - ?? ?? ? ??, 2005 - ????
... ???,???(??????????,????628000) ?? ... in patients with
esophageal cancer during the ... Was complications of lung an d ...
-

Source: Google Scholar
 

Study Reveals How Molecules Inhibit Growth Of Lung Cancer Cells

Article Date: 13 Mar 2007 - 0:00 PDT
By mapping the interlocking structures of small molecules and mutated protein "receptors" in non small cell lung cancer (NSCLC) cells, scientists at Dana-Farber Cancer Institute and their colleagues have energized efforts to design molecules that mesh with these receptors, potentially interfering with cancer cell growth and survival.

In a study published in the March issue of Cancer Cell, researchers led by Michael Eck, MD, PhD, of Dana-Farber used X-ray crystallography to determine the structure of two mutated forms of the epidermal growth factor receptor (EGFR) in lung cancer cells. EGFR, a protein known as a tyrosine kinase, plays a key role in relaying growth signals within cells. When mutated, it can become overactive, leading to excessive cell division and cancer.

"It turns out that in some cases, the very mutation that causes the cancer in the first place is also the cancer's Achilles' heel," said Eck, the paper's senior author. "We now see that inhibitors such as gefitinib actually bind more tightly to some of the cancer-causing mutants, even though they were originally developed to block the normal receptor."

Cai-Hong Yun, PhD, of Dana-Farber is the paper's first author.

Mutations in the EGFR kinase domain occur in approximately 16 percent of NSCLCs, but at much higher frequencies in selected populations, including nonsmokers, women, and East Asian patients. Laboratory and clinical studies have shown that tyrosine kinase inhibitors are more effective against some EGFR mutations than others, although the molecular reasons for this are unclear. By developing a better understanding of the effect of the mutations on inhibitor binding at a structural level, it may be possible to develop more effective therapies.

Article continues below and (thank you)

 
In the current study, Eck and his colleagues analyzed the three-dimensional structures of the normal and mutated versions of EGFR bound to several different types of inhibitor molecules. They found that two inhibitors the drug gefitinib (marketed as Iressa(R), and a compound called AEE788 bind especially tightly to one of the mutated forms, meaning these inhibitors are potentially more effective at blocking the growth of cancer cells containing that mutation. In the case of gefitinib, it bound 20 times more tightly to the L858R mutant than to the normal, mutation-free EGFR.

The research team concluded that the particular EGFR mutation within tumor cells determines which inhibitor molecules are likely to be able to slow or stop the growth of those cells.

"Although structural divergence in the EGFR mutants may complicate efforts to treat the disease, it may also present an advantage in that it introduces the possibility of developing inhibitors that target specific mutations, which should lead to more effective treatments," said Eck, who also an associate professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. "These targeted therapies likely would be less toxic as they, in theory, would not affect the normal functioning EGFR proteins."

In addition to Eck and Yun, the paper's other authors are Titus Boggon, PhD, formerly of Dana-Farber and now at Yale University School of Medicine; Yiqun Li and Michele Woo of Dana-Farber; and Heidi Greulich, PhD, and Matthew Meyerson, MD, PhD, of Dana-Farber and the Broad Institute of Harvard and Massachusetts Institute of Technology.

The research was supported with grants from the National Institutes of Health, the Leukemia and Lymphoma Society, and American Society of Hematology.

Dana-Farber Cancer Institute (http://www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute.

Dana-Farber Cancer Institute
44 Binney St., OS 382 A
Boston, MA 02215
United States
http://www.dana-farber.org/
 

Hormone paradox may help explain teen moodiness

Last Updated: 2007-03-12 9:01:14 -0400 (Reuters Health)

WASHINGTON - This might help explain why teenagers act like, well, teenagers.

Researchers reported on Sunday that a hormone produced by the body in response to stress that normally serves to calm adults and younger children instead increases anxiety in adolescents.

They conducted experiments with female mice focusing on the hormone THP that demonstrated this paradoxical effect, and described the brain mechanism that explains it.

If, as the scientists suspect, the same thing happens in people, the phenomenon may help account for the mood swings and anxiety exhibited by many adolescents, they said.

"Teenagers don't go around crazy all the time," lead researcher Sheryl Smith, a professor of physiology and pharmacology at the State University of New York Downstate Medical Center, said in a telephone interview.

"But it really is a mood swing where things seem fine and calm, and then the next thing is someone's crying or angry," she added. "And I think that's why people have used the term 'raging hormones'."

The emotional swings are not always benign, Smith's team reports in Sunday's issue of the journal Nature Neuroscience.

"Responses to stressful events are amplified, and anxiety and panic disorder first emerge at this time, being twice as likely to occur in girls as in boys," they wrote.

"In addition, suicide risk increases in adolescence, despite the use of adult-based medical strategies."

EXTRA RECEPTORS

THP, also called allopregnanolone, generally serves as a natural tranquilizer. It is not produced immediately with stress, but rather several minutes later, and calms neural activity to reduce anxiety and assist the individual in adapting and functioning amid stress.

"It's not the immediate fight-or-flight response," Smith said. "And it's thought to be one way that we all can compensate for stress, so we just stay focused and don't go crazy, sort of focus on our task."

Smith's team examined brain activity and behavior in mice before puberty, during puberty and as adults.

The researchers subjected the mice to a stressful event by suddenly placing them inside a plexiglas container just slightly larger than a mouse's body -- sort of a claustrophobic experience -- and keeping them there for 45 minutes.

"Twenty minutes after stress, both the young mice and the adult mice showed less anxiety. But the pubertal mice showed more anxiety," Smith said.

Further experiments attributed this increased excitability to the effects of THP, the researchers said. THP acts on brain cells via molecular doorways known as receptors.

During adolescence, mice have the usual receptors, but also extra-high levels of a second kind that brings an anxious, rather than calming, response when THP attaches to it.

"The parallel with humans is that in humans there are similar hormonal changes going on in puberty," Smith said.

"So the beginning of puberty is a time when a lot of emotions and responses to stress are increased. It's nothing new that teenagers go through a difficult time. Hopefully this will shed some new light on it."

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
Google
Web www.iconocast.com
 
 
Source for News : URL: http://www.medicalnewstoday.com and Reuters
Continue News With: News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast